Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection-Reference-Cited by-同舟云学术

Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection

Published:2018-03-28 Issue:12 Volume:24 Page:1361-1372
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Wei Lai,Wang Fu-Sheng,Zhang Ming-Xiang,Jia Ji-Dong,Yakovlev Alexey A,Xie Wen,Burnevich Eduard,Niu Jun-Qi,Jung Yong Jin,Jiang Xiang-Jun,Xu Min,Chen Xin-Yue,Xie Qing,Li Jun,Hou Jin-Lin,Tang Hong,Dou Xiao-Guang,Gandhi Yash,Hu Wen-Hua,Mcphee Fiona,Noviello Stephanie,Treitel Michelle,Mo Ling,Deng Jun

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference32 articles.

1. A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan

2. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

3. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

4. Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma

5. Chinese Society of Hepatology, Chinese Medical Association, Wei L; Chinese Society of Infectious Diseases, Chinese Medical Association, Hou JL. [The guideline of prevention and treatment for hepatitis C: a 2015 update]. Zhonghua Gan Zang Bing Za Zhi 2015; 23: 906-923

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals;Expert Opinion on Pharmacotherapy;2024-05-02

2. The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy;Current Drug Metabolism;2024-02

3. Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions;Cureus;2023-08-22

4. Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis;Journal of Clinical and Translational Hepatology;2020-09-11

5. Changes of inflammatory cytokines/chemokines during ravidasvir plus ritonavir‐boosted danoprevir and ribavirin therapy for patients with genotype 1b hepatitis C infection;Journal of Medical Virology;2020-06-29